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Severe	malaria	is	caused	by	the	apicomplexan	parasite	Plasmodium	falciparum.	
Despite	decades	of	research	the	unique	biology	of	these	parasites	has	made	it	
challenging	to	establish	high	throughput	genetic	approaches	to	identify	and	
prioritize	therapeutic	targets.		Using	transposon	mutagenesis	of	P.	falciparum	in	an	
approach	that	exploited	its	AT-rich	genome	we	generated	>38,000	mutants,	
saturating	the	genome	and	defining	mutability	and	fitness	costs	for	>87%	of	genes.	Of	
5,399	genes	our	study	defined	2,680	genes	essential	for	optimal	growth	of	asexual	
blood-stages	in	vitro.	These	essential	genes	are	associated	with	drug	resistance,	
represent	leading	vaccine	candidates,	and	include	∼1000	Plasmodium-conserved	
conserved	proteins	of	unknown	function.	We	validated	this	approach	by	testing	
proteasome	pathways	for	individual	mutants	associated	with	artemisinin	sensitivity.		
 
One Sentence Summary: (150 characters) Saturation-scale mutagenesis of Plasmodium falciparum reveals a 
core set of genes essential for asexual blood-stage growth in vitro.  
RESEARCH ARTICLE SUMMARY (structured abstract for online research article) 
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INTRODUCTION: Malaria remains a devastating global parasitic disease, with the majority of malaria deaths 
caused by the highly virulent Plasmodium falciparum. The extreme AT-bias of the P. falciparum genome has 
hampered genetic studies through targeted approaches such as homologous recombination or CRISPR-Cas9, 
and only a few hundred P. falciparum mutants have been experimentally generated in the past decades. In this 
study, we have used high throughput piggyBac transposon insertional mutagenesis and Quantitative Insertion 
Site Sequencing (QIseq) to reach saturation-level mutagenesis of this parasite.  
 
RATIONALE: Our study exploits the AT-richness of P. falciparum genome, which provides numerous 
piggyBac transposon insertion targets within both gene coding and non-coding flanking sequences, to generate 
over 38,000 P. falciparum mutants.  At this level of mutagenesis, we could distinguish essential genes as non-
mutable and dispensable genes as mutable. Subsequently, we identified 2,680 genes essential for in vitro 
asexual blood-stage growth.   
 
RESULTS: We calculated Mutagenesis Index Scores (MIS) and Mutagenesis Fitness Scores (MFS) to 
functionally define the relative fitness cost of disruption for 5,399 genes. A competitive growth phenotype 
screen confirmed that MIS and MFS were predictive of the fitness cost for in vitro asexual growth. Genes 
predicted to be essential included genes implicated in drug resistance, such as the “K13” Kelch propeller, mdr 
and dhfr-ts, as well as targets considered to be high-value for drugs development such as pkg, and cdpk5.  The 
screen revealed essential genes that are specific to human Plasmodium parasites but absent from rodent-
infective species, such as lipid metabolic genes that may be crucial to transmission commitment in human 
infections.  MIS and MFS profiling provides a clear ranking of the relative essentiality of gene ontology (GO) 
functions in P. falciparum. GO pathways associated with translation, RNA metabolism, and cell cycle control 
are more essential, whereas genes associated with protein phosphorylation, virulence factors, and transcription 
are more likely to be dispensable. Finally, we confirm that the proteasome-degradation pathway is a high-value 
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druggable target based on its high ratio of essential:dispensable genes, and by functionally confirming its link to 
the mode of action of artemisinin, the current front-line antimalarial.  
 
CONCLUSION: Saturation-scale mutagenesis allows prioritization of intervention targets in the genome of the 
most important cause of malaria. The identification of over 2,680 essential genes, including ~1000 
Plasmodium-conserved essential genes, will be valuable for antimalarial therapeutic research. 
 
Figure legend. 
Saturation-scale mutagenesis of Plasmodium falciparum reveals genes essential and dispensable for 
asexual blood-stage development. (A) A high-resolution map of a ~50 KB region of chromosome 13 depicts 
an essential gene cluster, including K13, that lack insertions in the coding sequence (CDS) but is flanked by 
dispensable genes with multiple CDS-disrupting insertions. (B)  The Mutagenesis Index Score (MIS) rates the 
potential mutability of P. falciparum genes based on the number of recovered CDS insertions relative to the 
potential number that could be recovered by large-scale mutagenesis. (C) The Mutagenesis Fitness Score (MFS) 
rates the relative fitness of P. falciparum genes based on QIseq scores of transposon insertion sites in each gene.  
 4 
 
Malaria caused by Plasmodium falciparum remains an insidious global health problem, with hundreds of 
thousands of deaths each year.  Recently there have been significant reductions in disease intensity, in part 
through concerted recent use of artemisinin-combination therapies, but these gains are now threatened by 
emerging ACT treatment failures spreading across South East Asia (1, 2).  If ACT resistance reaches Africa, a 
devastating rebound of disease is expected, as occurred with chloroquine resistance in the 1970s.  The 
development of new antimalarial therapies, and identification and prioritization of new targets, is a priority. 
More than a decade after the completion of the P. falciparum genome, a significant fraction of its genome still 
lacks functional annotation (3).  Although CRISPR-Cas9 and other targeted endonucleases will accelerate 
functional genomics studies (4-6), their usefulness for genome-scale applications is restricted by the absence of 
non-homologous end joining in Plasmodium parasites, and by the extreme AT-richness of the P. falciparum 
genome which reduces gRNA target site abundance. Therefore, a critical need remains for large-scale genetic 
analysis to systematically identify essential genes and prioritize parasite metabolic pathways for drug discovery 
(7).   
 Large-scale genetic screening methods in model organisms rely on efficient scalable methods for 
genome engineering.  Transposon mutagenesis using the piggyBac transposon, which preferentially inserts at 
the tetranucleotide target sequence TTAA, has been used to carry out whole-genome loss-of-function screens in 
many organisms (8-11). The highly skewed nucleotide composition of the P. falciparum genome, with >81% 
AT content, is an advantage for the application of piggyBac mutagenesis.  The skewed composition results in a 
high density of TTAA sites, averaging one site per 70 bp over both coding and non-coding regions, in theory 
allowing systematic and saturation-level mutagenesis of the whole genome. While piggyBac mutagenesis has 
been developed and optimized for P. falciparum, and previously used for small-scale phenotypic screens and 
functional characterization of loss-of-function mutants, it has not been used for large-scale screening (12-16). 
To scale up piggyBac mutagenesis in P. falciparum, we developed high-throughput transfection mutagenesis 
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methods that mostly create a single insertion per genome, and combined them with an Illumina-based 
sequencing method for identifying transposon insertion sites (17, 18). This approach, known as Quantitative 
Insertion-site Sequencing (QIseq), thus allowed whole-genome experimental mutagenesis analysis of P. 
falciparum (fig. S1, A and B).  
Achieving saturation-level mutagenesis 
 In a preliminary study we carried out large-scale transfections followed by short-term in vitro growth of 
mixed pools of drug-selected P. falciparum parasites and identified insertion sites by QIseq. This pilot 
identified a total of 3,651 insertions across the P. falciparum genome (table S1)(17, 19).  Based on the density 
and distribution of those insertions modeled by a Negative Binomial Distribution, we predicted that recovery of 
≥33,000 insertions would be sufficient to achieve saturation-level mutagenesis in the compact genome of the 
malaria parasite (fig. S1C-F); this number is sufficient for there to be a high probability that multiple transposon 
insertions would occur within the CDS of every protein-coding gene larger than 500 bp. We therefore scaled 
our transfection methods to achieve this number of insertions. Transfected parasite populations were drug-
selected briefly to isolate only mutant parasites with integrated piggyBac elements carrying the drug resistance 
gene hdhfr, before insertion-site locations were identified by QIseq.  Computational analyses were used to 
verify the sequence reads of the QIseq libraries and the consistency of the raw data (fig. S2A-F); nearly all 
QIseq-defined insertions occurred at the characteristic TTAA target sequence. All insertions sites that were not 
flanked by the consensus TTAA (2.49%) insertion sites were removed from subsequent analysis (fig. S2A). 
Previously validated individual piggyBac mutant clones were included in each QIseq run to act as a control for 
the accuracy and sensitivity of each insertion-site identification run (fig. S3A-C and table S2).  
 The saturation mutagenesis approach identified ~38,000 independent piggyBac insertions at distinct 
TTAA target sites, covering 5,399 nuclear protein-coding genes across all 14 chromosomes of the P. falciparum 
genome (Fig. 1A and table S3).  These randomly distributed insertions exceeded those predicted to be required 
to achieve saturation-level mutagenesis (Fig. 1A), but there were numerous genes and regions encompassing 
several genes that had significantly fewer insertions than would be expected based purely on the distribution of 
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TTAA-sites across the genome (Fig. 1B, C and D).  As well as discrepancies in non-random spatial distribution, 
coding regions overall lacked insertions compared with intergenic regions (p < 2.2e-16, Fisher test) (Fig. 1D). A 
more detailed analysis of piggyBac insertion density within transcriptional units revealed that insertions in CDS 
were threefold less common than in flanking intergenic regions, and even within intergenic regions, insertion-
site density decreased with proximity to CDS (Fig. 1E). This significant bias towards recovering intergenic 
insertions in surviving blood-stage parasites, with many CDS having no insertions, are indications that genes 
lacking insertions are lethal when disrupted by piggyBac insertion.  
Defining gene dispensability using mutagenesis index scores 
 While there was a bias against insertions in CDSs, 2,042 genes were disrupted by at least one piggyBac 
insertion (~38% of genes in the P. falciparum genome) (Fig. 1F). The remainder, 3,357 genes (~62% of the 
genome) had no insertions in their CDSs, and some of these were also completely devoid of insertions in the 
surrounding intergenic regions (2.9% of genes) (Fig. 1C, fig. S4A and table S4). In the 2,042 mutable genes, 
insertion sites were distributed uniformly along the gene body CDSs, indicating all disruptions have equivalent 
consequences for the disrupted gene (Fig. 1E).  The uniform distribution of transposon insertions throughout the 
genome is independent from chromatin structure and gene locations (fig. S4B). We therefore reasoned that the 
recovery of one or more insertions within the CDS of disrupted genes was an indicator of gene dispensability 
for in vitro asexual blood-stage growth.  Therefore, mutable genes are subsequently referred to as dispensable, 
while the absence of any insertions in the CDS could be considered an indicator that disruptions are lethal, and 
subsequently these genes are referred to as essential. However, the essential classification of 677 genes without 
insertions, which are small or with lower TTAA, is tentative, since they are below the average distance between 
recovered insertions (<613 nt)(table S5).  To quantify the evidence for dispensability or essentiality of each 
gene we developed a mutagenesis index score (MIS) based on the number of identified piggyBac insertions 
relative to the number of available TTAA target sites within that gene (Fig. 2A and table S5).   Genes with 
higher MIS (on a scale of 0 to 1) were considered to have a higher possibility of dispensability, while those with 
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lower MIS were considered to have a higher possibility of essentiality. The 2000 genes with highest and lowest 
MIS represent mutability characterization with the strongest confidence.   
Biological processes identified as dispensable and essential 
Mutants in the lowest MIS quartile were enriched in core metabolic processes shared across eukaryotes, 
which would be predicted to be essential. Mutants in the highest MIS quartile were enriched in parasite-specific 
multi-gene families that interact directly with the host, and which are known to be partially functionally 
overlapping and contain many redundant genes (Fig. 2B). It is important to note that this screen was carried out 
using in vitro cultured parasites, and many of these in vitro dispensable genes, such as those for antigenic 
variation and cytoadherence, have greater importance in vivo in human infections (fig. S5).  The dispensability 
of parasite processes involved in host-parasite interactions contrasted with the essentiality of internal parasite 
processes, such as those associated with RNA metabolism (Fig. 2C-D, fig. S6 and table S6).  RNase II, a gene 
implicated in a post-transcriptional regulatory mechanism relevant to severe malaria, is an example with a low 
MIS score, consistent with previous reports of the locus being refractory to disruption (20). Other genes 
involved in general RNA metabolism that have low MIS include both widely-conserved RNA-binding proteins 
(such as PABP) and apicomplexan-specific RNA-binding proteins likely to have more specific, mostly 
unidentified, regulatory targets. The P. falciparum genome has an abundance of RNA-binding proteins that are 
largely functionally uncharacterized and our analysis suggests that many of these genes are likely to be 
essential. 
MIS therefore correlates with what is known broadly about the importance or redundancy of metabolic 
pathways. To further validate that MIS is a good predictor of essentiality, we analyzed genes that have been the 
focus of drug or vaccine development. Genes strongly predicted to be essential based on MIS included the 
“K13” Kelch propeller implicated in artemisinin resistance, as well as other genes implicated in drug resistance, 
such as DHFR-TS, MDR and AAC2, involved in pyrimethamine, mefloquine and atovaquone reistance, 
respectively.  Other genes classified as essential based on MIS included ones considered high priority blood-
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stage drug targets such as PKG, and CDPK5. By contrast, most blood-stage vaccine candidates were 
dispensable, with the notable exception of RH5.  Not unexpectedly, sporozoite vaccine candidates CSP and 
TRAP, which are essential for sporozoite development in mosquitoes but are not required in blood-stage 
development (21), had high MIS. In contrast, the gene for pore-forming protein Cell Traversal of Ookinetes and 
Sporozoites (CelTOS) had low MIS. CelTOS is important for these parasite migratory phases and is emerging 
as a pre-erythrocytic-transmission blocking vaccine candidate; its low MIS indicates it may also have an 
essential function in blood-stage infections, making it a potential multi-stage vaccine target. MIS analysis also 
revealed likely essential genes that are specific to human Plasmodium parasites but absent from rodent-infective 
species, such as the lipid metabolic genes (PCD, PMT) that are crucial in the development of mosquito-
transmissible sexual-stages in P. falciparum (22, 23). 
Mutant growth fitness as a measure of gene dispensability 
We previously developed a phenotyping method in which a pool of piggyBac mutants were grown as mixed-
mutant pools over multiple generations, and the number of reads for each piggyBac insertion site quantified 
using next-gen sequencing to measure parasite growth rates (17). We adapted this method to generate a second 
quantitative measure of gene dispensability independent from MIS, by comparing the normalized number of 
reads from each insertion site to the total pool of reads across all P. falciparum mutants in the saturation 
mutagenesis screen (Fig. 2E and table S5). This mutagenesis fitness score (MFS) serves as a proxy for mutant 
growth fitness. MFS scores strongly correlated with MIS scores, despite the fact that they are independent of 
each other (Fig. 2F). The MFS of mutable genes was high, in keeping with the MIS prediction of dispensability, 
while predicted essential non-mutable genes had a low MFS (Fig. 2G). Intermediate MIS and MFS scores were 
weakly correlated, in keeping with the lower confidence that we can place on the essentiality or dispensability 
of genes with these intermediate scores.  
 A competitive in vitro growth screen (17) was used to phenotype four separate pools of mixed-mutant 
populations to provide additional validation of the correlation between MIS and a gene’s importance for growth 
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fitness.  Mutable genes with high MIS had low or minimal fitness cost were competitive growth ‘winners’, 
whereas growth fitness ‘losers’ had relatively low MIS (Fig. 3A and table S7). Relatively few mutations had 
little or no fitness cost, as measured by MFS, resulting in a disproportionate number of mutant ‘losers’ (Fig. 
3B). Overall both the MIS and MFS were predictive of the fitness cost for in vitro asexual growth (Fig. 3C), and 
between these metrics we were able to predict separate 5,399 genes in the P. falciparum genome into non-
mutable and mutable categories (Fig. 3D and E).    
Association of essentiality with genome structure and transcription patterns 
Dispensable and essential genes rarely occurred as single isolated genes, but rather occurred as multi-gene 
clusters reminiscent of conserved syntenic blocks (Fig. 1A, C and fig. S4A)(24). We therefore assessed the 
relationship between evolutionary conservation of genome structure and essentiality/dispensability by using 
previously defined syntenic relationships between Plasmodium spp. (25).  Syntenic genes indeed had lower 
MIS, suggesting conserved essential functions across Plasmodium spp.; conversely, non-syntenic genes were 
more likely to be dispensable (Fig. 4A). Mapping chromosomal regions with synteny breaks, which typically 
harbor gene duplications and paralogs, showed patterns of clustering of essential and dispensable genes in 
syntenic and non-syntenic chromosomal regions, as seen in examples for chromosomes 13 and 10 (Fig. 4B-E).  
 Transcription metrics for each gene based on maximum FPKM values (26) were examined for 
correlations with essentiality and dispensability (Fig. 5A).  This analysis showed that essential genes are 
expressed at significantly higher levels throughout both the asexual and sexual life cycle phases, indicating they 
may have critical functional roles throughout both the mosquito and human stages and therefore represent 
potential multi-stage drug targets (Figs. 5B and C). Within the intraerythrocytic cycle, genes with peak 
expression during the trophozoite stage were more likely to be essential than those expressed during other 
stages (Fig. 5C).  During the trophozoite stage, P. falciparum must acquire nutrients from the host and remodel 
the infected erythrocyte to avoid host defenses, such as clearance by the spleen. In contrast, dispensable 
processes were enriched at either end of intraerythrocytic development, reflecting parasite stages with a greater 
need for functional redundancy, such as those involved in host interaction (e.g., erythrocyte invasion, antigenic 
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variation), and are hence more likely to undergo duplication/paralog evolution. Not unexpectedly, about 41% of 
the dispensable genes are predominantly expressed in sexual stages (Fig. 5C).  These genes may be essential for 
transmission to or from the mosquito, but do not appear to have an essential function for asexual blood-stage 
development. The high coverage of sexual-stage genes in this screen emphasizes the potential for piggyBac-
based screens for identifying sexual phenotypes.   
Evolutionary conservation of apicomplexan gene essentiality 
 We compared the data from our genome-wide saturation screen with data from large-scale genome 
sequencing studies of P. falciparum, as well as data from recent large-scale mutagenesis studies of 
apicomplexan genomes (6, 18, 27-29) to evaluate the conservation of gene essentiality across the organisms’ 
lineages.  Essential P. falciparum genes were more highly conserved across Plasmodium spp. (Fig. 5D and fig. 
S8A), are less likely to have a paralog (Fig. 5E and fig. S8B), and encode genes with less genetic variation 
among P. falciparum clinical isolates (Fig. 5F and fig. S8C).  Of the P. falciparum genes studied here, 2,083 
and 1,998 have orthologs in the more distantly-related parasites Toxoplasma gondii (6) and P. berghei (29), 
respectively. Overall, there was a strong correlation in gene function between species, particularly with genes 
predicted as essential (Fig. 5G and H and fig. S8D and E). Genes that are dispensable in P. falciparum were also 
more likely to be dispensable in P. berghei. By contrast, the correlation between the dispensable genes of P. 
falciparum and T. gondii was weaker, indicating that genus-specific gene functions are enriched for 
dispensability.  Overall, these comparisons show that while phenotype classifications from the large-scale 
mutagenesis screens in apicomplexan species are also broadly predictive of the P. falciparum phenotype 
classifications, the closer evolutionary relationship of P. berghei provides a higher level of sensitivity and 
specificity for the orthologs that could be disrupted (Fig. 5I and fig. S8F).  
 Consistent with this assessment that non-mutable genes represented core essential functions in P. 
falciparum, GO enrichment analysis indicated genes with functions associated with translation, RNA 
metabolism, and cell cycle control were more likely to be essential, whereas genes associated with protein 
phosphorylation, virulence factors, and transcription were more likely to be dispensable (Fig. 6A). Comparing 
 11 
the relative number of essential, versus dispensable, genes within specific GO biological processes, molecular 
functions, and cellular components provided a ranking of the essentiality of potential druggable targets and 
pathways (Figs. 6A-C, figs. S9A-C and table S8).  For example, nearly all genes annotated as being involved in 
ubiquitin-dependent degradation processes were experimentally defined as essential, while individual genes 
linked to microtubule motility and antigenic variation are experimentally defined as dispensable based on MIS. 
RNA metabolism and translation-related processes are also highly essential, supporting emerging evidence for 
the importance of post-transcriptional and translational control (30).  
Essentiality of the proteasome-degradation pathway 
 Recent genetic analysis of artemisinin-combination therapy resistance has linked drug resistance to 
cellular stress-response mechanisms involving the P. falciparum ubiquitin/proteasome system (31, 32).  Genes 
of the proteasome-degradation pathway were well represented in the piggyBac insertion set, and 54 of the 72 
genes could be classified as essential genes based on our data (fig. S10A), further strengthening the priority of 
the proteasome degradation pathway as a high-value druggable target (33).  We validated this link between 
artemisinin sensitivity and proteasome inhibition sensitivity using a set of single-insertion piggyBac mutants 
previously defined by chemogenomic profiling to be part of an artemisinin-sensitivity cluster, including a 
mutant of the K13 Kelch propeller gene (16, 34).  We found ten-fold increased sensitivity to the proteasome 
inhibitor Bortezomib in mutants of the artemisinin-sensitivity cluster; significantly different relative to wild-
type NF54 or mutants with distinct chemogenomic profiles (fig. S10B-E), providing additional support for the 
association between the ART mechanism of action and proteasome function.  
Summary	
 In conclusion, our genome-wide saturation mutagenesis screen in the major human pathogen, P. 
falciparum has defined genes essential for parasite survival during the blood stage and provided critical 
functional data for prioritizing high-value drug targets and pathways. The complete characterization of the 
essential genome with high-throughput saturation mutagenesis will help open new frontiers for antimalarial 
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therapeutic research. The methodology also opens the way for new systematic functional screens for other 
phenotypes, such as transmission and cytoadherence. 
 
Materials and Methods 
Parasite culture 
All P. falciparum parasite NF54 and piggyBac mutants were cultured in complete RPMI 1640 with 5% 
hematocrit (medium containing 0.5% Albumax II, 0.25% sodium bicarbonate and 0.01 mg/ml gentamicin). All 
parasite cultures were maintained by standard methods (35).  
 
piggyBac Transfection (35) 
High-efficiency transfection (96-well plate method) was carried out on NF54 schizonts purified by 
magnetic column (MiltyenyiBiotec, CS column) using a transposon plasmid (pLBacII-HDH, containing 
selection marker human dhfr) and a transposase-expressing helper plasmid (pDCTH)(19). RBCs were first 
loaded with plasmid DNA by electroporation using Gene PulserXCell+CE Module (BioRad). A total of 10 
million schizonts, 1200 µg plasmid DNA and 600 µg helper plasmid DNA were used per 96-well plate to 
achieve maximal transfection efficiency. The drug WR99210 (final concentration 2.5 nM) was added to each 
plate for selecting transfected parasites, using a robot (Integra VIAFLO 96) to change media with drug every 
day for 5 days. Transfections were performed in batches over the course of 4 to 6 weeks. Each 96-well plate 
was cultured in triplicate and cryopreserved in duplicate. One hundred 96-well plates were used to generate the 
large pools for sequencing (fig. S1A).  
For maximum recovery of unique mutants, the transfected culture was distributed into 96-well plates by 
robot (200µl each well) and grown under two rounds of drug selection. Wells were screened for parasites by 
PCR and Giemsa-stained thin blood films. >50% of wells became parasite-positive within three weeks. Each 
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positive well with ³9 unique mutants (one well = one “Mixed Population”, or MP) was cryopreserved in 
duplicate (two 96 well plates). Additional 96-well plates were used to generate the pools that were then cultured 
in a T75 flask and harvested after two cycles growth by standard methods for genomic DNA isolation for QIseq 
(17).  Although mutants grow at different rates, the pools can be expanded for at least 12 asexual life cycle 
generations (“cycles”) without significant loss in detectable diversity.  Importantly, each mutant pool can be 
regenerated and cloned from their original MPs. 
 
Datasets of reference genomes, transcriptome data and epigenetics data 
The NF54 reference genome can be downloaded from 
(ftp://ftp.sanger.ac.uk/pub/project/pathogens/Plasmodium/falciparum/NF54/Assembly/V1_morphed/). The 
QIseq sequencing mapping followed previously published methods (17). Ortholog counts, paralog counts, and 
non-synonymous/synonymous (NonSyn/Syn) ratios can be downloaded from PlasmoDB 
(http://plasmodb.org/plasmo/) (36). Previously published RNA-seq expression data (26, 37) are used in 
computational analysis. Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE-seq) data of seven 
time points (0, 6, 12, 18, 24, 30 and 36 hour) were used to measure chromatin accessibility (38). The motif 
information of transcription factor ApiAP2 binding sites is available in previously published work (39). The 
genome synteny across five Plasmodium species is available in published work (25). 
 
Identification of > 38,000 mutants carrying piggyBac insertion 
The QIseq sequencing generated a total of 3,301,112 raw reads. First, all the raw reads were filtered by 
the criteria of matching expected transposon target site ‘TTAA’. This filtering step yielded 2,042,147 reads, 
which is >6-fold genome coverage. The insertion site QIseq signal was calculated as the reads count of the 
filtered QIseq reads. To compare the insertion signals between different QIseq runs, we normalized for each 
insertion i as 
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, where Sj represents the signal of the insertions i with reads counts ci in run R. All the piggyBac insertions with 
reads in both 5ʹ and 3ʹ ends were treated as true insertions by using an extremely high level of accuracy in target 
site (target motif TTAA ~ 99%).  To identify true insertions with reads only in single 5ʹ or 3ʹ ends, we used a 
method that selected the most accurate signal cutoff based on the ratio of the number of input reads/ the number 
of output disrupted genes. We computed the number of gene CDSs targeted by the insertions upper cutoff (i.e. 
more accurate). We noticed that there was a single large and sharp increase in the number of CDSs targeted by 
the insertions with reads number increasing from cutoff 2.0 to cutoff 2.3 (Fig. S2E, p < 0.05 compared with 
changing another cutoff). The result indicated a large amount of false positive may be included when setting 
cutoff ≥ 2.3.  Therefore, the normalized reads count = 2.3 was set as the lower bound for identifying true 
insertions.  
 
Mutagenesis saturation computational validation 
To evaluate the levels of whole-genome mutagenesis and eventual saturation, we used a computational 
method based on sampling.  First, a specific number of insertions were randomly extracted and the fraction of 
genome elements targeted were counted. This procedure was repeated 1000 times for each query insertion 
number in fig. S1C. A log-based curve was observed by plotting the mutational events and the median number 
of genome elements targeted by insertions. The plateauing of the curve at about 20,000 mutational events 
indicated that a very small number of new genome elements could be targeted even with very large amount of 
insertions. Importantly, the real data-based sampling curve was very similar to our independent mathematical 
predictions of Negative Binomial distributions prior to the start of the saturation mutagenesis experiments (fig. 
S1D). Together, both our mathematical model and real-data computational sampling show that > 33,000 
mutants represent saturation-level mutagenesis of the entire set of protein-encoding genes in the P. falciparum 
genome. 
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Sampling methods for accounting for fragment length differences and nucleoside composition bias  
For genes in the P. falciparum genome, 5ʹ upstream and 3ʹ downstream intergenic regions displayed 
similar TTAA densities (median number of TTAA sites per 100bp were 1.82 and 1.89, respectively). However, 
they have significantly different region length distributions (median values are 1681bp and 926bp in 5ʹ and 3ʹ 
direction, respectively; p< 0.001 Wilcoxon test). Therefore, there are different numbers of genomic TTAA sites 
in 5ʹ and 3ʹ intergenic regions, as an intrinsic feature of the P. falciparum genome. To account for this region-
length and total-TTAA bias in our QIseq calculations, the TTAA sites in 3ʹ intergenic regions were sampled 
based on the TTAA number in 5ʹ intergenic regions, so that our comparison was based on two identical 
background target-site distributions. Distribution of insertions and TTAA sites (Fig. 1E) were plotted based on 
these sampling data.  
 
Mutagenesis index score (MIS) calculation 
To quantify the mutability of every protein-coding gene in the P. falciparum genome, we first checked 
the number of piggyBac insertions located inside the gene CDS regions. To keep the criteria stringent, the 
insertions located on the very end (distance from insertion to TSS > 99% of the CDS length) of the CDS were 
not considered, due to a significantly higher number of insertions at the last 1% of the CDS compared with 
other regions of the CDS (fig. S2F). We calculated the initial score MIS of gene 𝑀𝑆𝑔 based on the equation 
𝑀𝑆/ = log	(567896 )              (2) 
where 𝑁/ represents the number of insertions on gene 𝑔. 𝐷/ is the TTAA density of the gene	𝑔, which could be 
represented as the number of TTAA per kb of the CDS. We found that the MS could be decomposed into two 
mixed Gaussian distributions (Fig. S11). We reasoned that dispensable and essential genes exhibit different MS 
distribution. Therefore, a binary variable 𝜋/ was used to model whether the gene 𝑔 is dispensable or not: 𝜋/ 	=
 16 
1 corresponds to dispensable and vice versa. The probability of observing a 𝑀𝑆/ of gene 𝑔 is mixture of two 
Gaussian distributions: 
𝑃 𝑀𝑆/ = 𝑃(𝜋/)𝑁(𝑀𝑆/|𝜇B6, 𝜎B6)B6E8,F 															 𝑃 𝜋/ = 1B6E8,F 			        (3) 
Subsequently, the EM algorithm was implemented to search for the optimized value of parameters. The 
posterior distribution after the EM optimization procedures could be calculated as: 
𝑃 𝜋/ = 1 𝑀𝑆/, Θ = H(B6E8)5(IJ6|KL6MN,OL6MN)H(B6)5(IJ6|KL6,OL6)L6MN,P             (4) 
,where Θ is the parameter space. The MIS was defined as the posterior distribution to be dispensable. 
 
Mutagenesis fitness score (MFS) calculation 
For the mutants that were subjected to competitive growth essay, we calculated MFS to represent the 
comparative growth fitness of a mutant. The QIseq sequencing reads distribution reflects the fitness of unique 
piggyBac mutants in the competitive-growth assays. The start and the end of the growth assay could be 
represented as 𝑡Fand 𝑡. At the end of the assay, 𝑎S,/T,Uindicateed the relative abundance of each mutant m, 
targeted into the CDS of gene 𝑔 in sample v. Therefore, the abundance of the mutant of the gene 𝑔 at the end of 
the assay could be represented as 𝑎S,/T,UTVU . The 𝑎S,/T,UTVU  was directly proportional to the QIseq reads 
number 𝑟S,/T,UTVU . Here, 𝑟S,/T,U represents the normalized reads number of mutant m targeting gene 𝑔	on CDS, 
which is 𝑎S,/T,UTVU 	~ 𝑟S,/T,UTVU . The QIseq reads starting with ‘TTAA’ were used to measure 𝑟S,/T,U. To 
normalize different 𝑟S,/T,UTVU in different sample v, the average value of 𝑟S,/T,UTVU  was calculated as  𝑟S,/T,UT / 𝐼(𝑚	𝑜𝑛	𝑔)TU                (5) 
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Here, 𝐼(∙) is the indicator function. 𝐼(𝑚	𝑜𝑛	𝑔)T  was the number of mutants targeting gene 𝑔 in all samples. 
At the start of the assay 𝑡F, the relative abundance of each mutant equal to the background TTAA density 𝐷/. 
Finally, the MFS could be calculated as: 
𝑀𝐹𝑆/ = 	log	( a`,6b,cb / d(T	ef	/)bc 96 )                         (6) 
Therefore, the MFS calculation based on individual mutant abundance is a proxy for competitive growth fitness 
in in vitro blood stage. 
 
GO analysis 
All the Gene Ontology (GO) terms were downloaded from (http://plasmodb.org/plasmo/)27. For each 
specific GO term 𝑔, the MIS distribution in the term 𝑔 could be represented as 𝑀𝐼𝑆/. The number of genes in 
term 𝑔 is 𝑁𝑢𝑚/. We asked whether the genes in the term 𝑔 are more prone to be dispensable or essential. To 
answer this question, we compared the median value of 𝑀𝐼𝑆/ with sampled data distribution as background. 
The genes with the same number of 𝑁𝑢𝑚/ were sampled out and represented as 𝑆/. This procedure was 
repeated 1000 times and the median MIS of each 𝑆/,S	(𝑡	 ∈ 1,2,3. .1000) was calculated as 𝑀𝐼𝑆J6,a. The p-value 
was calculated as  
𝑝/ = 𝐼 𝑀𝐼𝑆/ > 	𝑀𝐼𝑆J6,a	8FFFSE8 /1000										(𝑀𝐼𝑆/ > 0.5)𝐼 𝑀𝐼𝑆/ < 	𝑀𝐼𝑆J6,a	8FFFSE8 /1000										(𝑀𝐼𝑆/ < 0.5)                  (7) 
Here, 𝐼(∙)is the indicator function. 
                  
Half-maximal inhibitory concentration (IC50) estimation 
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To calculate IC50, the dose-response data (e.g., drug concentrations c1, c2, …cn and growth inhibition q1, q2, … 
qn) were used to fit a Hill Equation. 
                                                    (8) 
where c was drug concentrations in logarithmic form. The parameter C was the estimate of IC50. The goodness 
of fit was calculated from dose-response data and the Hill Equation.  
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Figure legends  
 
Fig. 1.  A genome-wide saturation mutagenesis screen for Plasmodium falciparum. 
(A) Chromosomal map displays 38,173 piggyBac insertion sites from all mutants evenly distributed throughout 
the genome. (B) High-resolution map of a ~50 KB region of chromosome 13 depicts an essential gene cluster, 
including K13, flanked by dispensable genes with multiple CDS-disrupting insertions. (C) High-resolution map 
of a ~20 KB region without insertions includes three conserved genes of unknown function (PF3D7_1232700, 
PF3D7_1232800, PF3D7_1232900) and a putative nucleotidyltransferase (PF3D7_1232600) (see also fig. S5). 
(D) A plot of all piggyBac insertions revealed significantly fewer insertions were recovered from exon-intron 
regions compared to the proportion of available TTAA sites (see also fig. S1D) (p < 2.2e-16, Fisher’s Exact 
test). (E) Density of piggyBac insertion-site distribution revealed threefold fewer insertions recovered in 
transcriptional regions (blue) than intergenic 5ʹ (yellow) and 3ʹ (green) regions, depicted as relative distance 
upstream and downstream to a gene, respectively. (F) This study determined that under ideal culture conditions 
for asexual blood-stage growth, 38% of genes in the P. falciparum genome have mutable CDSs, while 62% of 
genes have non-mutable CDSs, which includes 12% with tentative classification. 
 
Fig. 2. Identification of dispensable and essential genes through Mutagenesis Index Score (MIS) and 
Fitness Score (MFS).  
(A) The Mutagenesis Index Score (MIS) rates the potential mutability of P. falciparum genes based on the 
number of recovered CDS insertions relative to the potential number that could be recovered. Genes known as 
dispensable or essential are highlighted.  (B) MIS violin plots of GO processes grouped from lowest to highest 
dispensability, according to gene functional annotations. (C) MIS plots and (D) high-resolution chromosome 
maps highlighting important genes of interest for RNA metabolism [-20kb, +20kb] (see also fig. S4 for MIS 
plots of other genes of interest. (E) The Mutagenesis Fitness Score (MFS) estimates the relative growth fitness 
 22 
cost for mutating a gene based on its normalized QIseq sequencing reads distribution. (F) MIS has significant 
correlation to MFS (Pearson’s R = 0.67, p < 2.2e-16 compared with permutation). (G) The first and second 
MFS quartiles were comprised primarily of non-mutable genes, the 4th quartile was comprised mostly of 
mutable genes, and 3rd quartile had nearly equal numbers of both.  
 
Fig. 3. Validation of mutagenesis score through phenotype screen. 
(A) Competitive growth assays of asexual blood-stage growth under ideal in vitro culture conditions: 
phenotypes of four independent mixed-population pools grown for three cycles confirmed losers (left, bottom 
quantile) and winners (right, top quartile) had significantly different MIS. (B) Overall rank-ordered plot of 
competitive growth phenotypes shows losers and winners. (C) Competitive growth ‘losers’ had significantly 
lower MIS and MFS, respectively, validating MIS and MFS as predictor of gene essentiality and dispensability. 
(D) Circos plot from outer to inner shows the distribution of all piggyBac insertions, MIS (pink indicates MIS < 
0.5, while blue is >0.5), CDS insertions, and MFS along each chromosome of P. falciparum genome. (E) Violin 
plots indicate non-mutable genes had significantly lower MIS and MFS (‘****’ represents Wilcoxon p < 2.2e-
16).   
 
Fig. 4. Chromosomal syntenic breakpoints are enriched in dispensable genes.  
(A) Genes within conserved syntenic blocks have significantly lower MIS and MFS (Wilcoxon p < 2.2e-16). 
Syntenic genes or “syntenic block” is defined as at least three genes in the same order on the same chromosome 
as their orthologs in another species within a 25-kb search window.  (B and C) Scatter plots show the insertion 
site enrichment along two syntenic breakpoints (Ch13:2,110,000 -2,135,000, Chr10: 642000-666000). Each gap 
in synteny (white area) is enriched for piggyBac insertions while flanked by essential regions (green shading); 
black boxes represent the location of CDS. (D and E) Circos plots indicate the syntenic blocks of P. falciparum 
in relation to other Plasmodium spp. (P. berghei, P. chabaudi, P. knowlesi, P. vivax). 
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Fig. 5. Distinct biological process and evolutionarily conservation segregate the tendency of dispensable 
and essential genes.  
(A) The genes with lowest FPKM expression value (first quantile) among different stages were enriched for 
dispensable genes (Wilcoxon P < 2.2e-16 compared with other quantiles)(26). The expression level cut off is set 
at 20 FPKM. (B) Non-mutable essential genes had significantly higher expression value for blood-stage 
development. (C) The group of trophozoite-stage genes had the highest proportion of essential genes (red) 
whereas gametocyte genes had the highest proportion of dispensable genes (blue) (Wilcoxon p < 1e-12). (D to 
F) Characteristics of essential genes significantly different from dispensable genes include: (D) 1:1 ortholog 
conserved among Plasmodium spp; (E) absence of paralogs; and (F) reduced rate of non-synonymous to 
synonymous SNPs. Bars indicate the group median (‘****’ indicates Wilcoxon p < 2.2e-16). (G and H) 
Essential genes reported in (G) Toxoplasma and (H) P. berghei showed significantly lower MIS in this 
mutagenesis screen of P. falciparum (‘****’ indicates Wilcoxon p < 2.2e-16).  (I). Plot of Receiver Operating 
Characteristics (ROC) indicate the level of retention of essential genes across species. The MIS of P. falciparum 
more strongly correlates with the essentiality phenotype of P. berghei than Toxoplasma.   
 
Fig. 6. Differentiating dispensable and essential genes and discovering high-priority druggable targets 
and pathways.  
(A) Functional annotations of biological processes are represented by the p-value and the X-axis shows the 
fraction of the genes with MIS > 0.5. Each GO term is assigned a p-value on the Y-axis to represent the 
tendency to be essential or dispensable. Essentiality is indicated on a spectrum of red (essential) to blue 
(dispensable) and circle sizes indicate the GO term enrichment.  (B and C) Boxplot of (B) molecular processes 
and (C) cellular components shows the MIS distribution generated by 1000x sampling of the number of genes 
in the query GO-term category. Left (red) and right (blue) triangles indicate GO terms with significantly lower 
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or higher MIS (p-value < 0.05 compared to background), respectively; the heatmap represents the essentiality 
defined as the fraction of genes per GO term with MIS > 0.5.   
 
